ALLIANCEBERNSTEIN L.P.

Position in EYPT — EyePoint, Inc.

CIK 1109448 NASHVILLE, TN

Position in EYPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$971,081

-$400,813 QoQ

Shares Held

75,336

+0.3% QoQ

Ownership

0.090%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ALLIANCEBERNSTEIN L.P. holds $5,113,566,936 across 211 Biotechnology names. EYPT ranks #112 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,910,786	$1,746,322,380
2	REGN	Regeneron Pharmaceuticals, Inc.	426,914	$329,850,832
3	ARGX	Argenx SE	422,304	$308,387,496
4	GMAB	Genmab A/S	9,557,149	$256,418,307
5	BBIO	BridgeBio Pharma, Inc.	1,908,907	$141,755,433
6	TECH	BIO-TECHNE Corp	2,213,197	$115,661,675
7	INSM	INSMED Inc	688,734	$112,621,783
8	HALO	Halozyme Therapeutics, Inc.	1,736,501	$112,230,059

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$971,081	75,336	+0.3%	Shares	Defined	2026-05-15
2025-12-31	$1,371,894	75,090	+28.2%	Shares	Defined	2026-02-17
2025-09-30	$834,321	58,590	0.0%	Shares	Defined	2025-11-14
2025-06-30	$551,331	58,590	+15.1%	Shares	Defined	2025-08-14
2025-03-31	$275,823	50,890	+16.2%	Shares	Defined	2025-05-15
2024-12-31	$326,235	43,790	0.0%	Shares	Defined	2025-02-12
2024-09-30	$349,882	43,790	-15.4%	Shares	Defined	2024-11-14
2024-06-30	$450,312	51,760	+87.5%	Shares	Defined	2024-08-14
2024-03-31	$570,492	27,600	+22.1%	Shares	Defined	2024-05-14
2023-12-31	$522,286	22,600	+14.0%	Shares	Defined	2024-02-14
2023-09-30	$158,361	19,820	+34.1%	Shares	Defined	2023-11-14
2023-06-30	$128,586	14,780	—	Shares	Defined	2023-08-15
No filing history on record for this holder in this stock.